CAPS - Capstone Therapeutics Corp.

Stock Grade Analysis

General Rating

B-

Overall Score: 2/5

Multi-dimensional Scores

DCF: 5/5 ROE: 1/5 ROA: 1/5 D/E: 1/5 P/E: 1/5

Financial Ratios Trend

Grades Consensus

0

Strong Buy

1

Buy

0

Hold

0

Sell

0

Strong Sell

Buy

Consensus

Grade News & Updates

Date	Grading Company	New Grade	Previous Grade	Action	Price When Posted	News Title	Publisher
2023-09-28	William Blair	Outperform	Outperform	Hold	$7.5	Bionomics' Victory - Analysts Note Optimism Around Promisin…	Benzinga